Language:

Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment

Critical care (London, England), 2017-08, Vol.21 (1), p.211-211, Article 211 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1364-8535 ;EISSN: 1466-609X ;DOI: 10.1186/s13054-017-1801-3 ;PMID: 28807042

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment
Author: Hassoun, Ali ; Linden, Peter K ; Friedman, Bruce
Subjects: Analysis ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antimicrobial agents ; Bacteremia ; Bacteremia - drug therapy ; Bacteremia - epidemiology ; Care and treatment ; Clinical outcomes ; Diagnosis ; Diagnostic tests ; Epidemiology ; Gram-positive bacteria ; Health surveillance ; Hospitals ; Humans ; Incidence ; Intensive care ; Management ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - pathogenicity ; Mortality ; MRSA ; MSSA ; Pathogens ; Penicillin ; Prevalence ; Prevalence studies (Epidemiology) ; Review ; Risk factors ; Staphylococcus aureus ; Staphylococcus infections
Is Part Of: Critical care (London, England), 2017-08, Vol.21 (1), p.211-211, Article 211
Description: Methicillin-resistant Staphylococcus aureus (MRSA) infection is still a major global healthcare problem. Of concern is S. aureus bacteremia, which exhibits high rates of morbidity and mortality and can cause metastatic or complicated infections such as infective endocarditis or sepsis. MRSA is responsible for most global S. aureus bacteremia cases, and compared with methicillin-sensitive S. aureus, MRSA infection is associated with poorer clinical outcomes. S. aureus virulence is affected by the unique combination of toxin and immune-modulatory gene products, which may differ by geographic location and healthcare- or community-associated acquisition. Management of S. aureus bacteremia involves timely identification of the infecting strain and source of infection, proper choice of antibiotic treatment, and robust prevention strategies. Resistance and nonsusceptibility to first-line antimicrobials combined with a lack of equally effective alternatives complicates MRSA bacteremia treatment. This review describes trends in epidemiology and factors that influence the incidence of MRSA bacteremia. Current and developing diagnostic tools, treatments, and prevention strategies are also discussed.
Publisher: England: BioMed Central Ltd
Language: English
Identifier: ISSN: 1364-8535
EISSN: 1466-609X
DOI: 10.1186/s13054-017-1801-3
PMID: 28807042
Source: MEDLINE
PubMed Central
Alma/SFX Local Collection
Springer Nature OA/Free Journals
ProQuest Central
DOAJ Directory of Open Access Journals

Back to results list

Previous Result 7 Next Go to Next page


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment

COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1364-8535 ;EISSN: 1466-609X ;DOI: 10.1186/s13054-017-1801-3 ;PMID: 28807042

Searching Remote Databases, Please Wait